ICICI Prudential posted its Q4FY18 with net profit down 16.6% at Rs 340Cr Vs Rs 408Cr on YoY basis. To decode and discuss the quarter gone by in detail, we caught up with Santosh Singh of Haitong Securities.
Shishir Shrivastava, Joint MD at Phoenix Mills says they are aiming equity return of 23-26% from the Bengaluru project and expect mall project to be operational in 36 months.
Anand Deshpande, Founder and CMD at Persistent Systems says the capacity utilisation rate is above 80%; expecting increase in headcount this quarter.
The new ordinance on IBC may look at extending the resolution timeline among other changes. Meghna Mittal joined us with the details.
Nitin Soni of Fitch Ratings says the Bharti Infra-Indus tower merger will benefit Vodafone & Idea and they will monetise their stake in Indus tower deal.
Qi Gao, Currency Strategist - EM Asia at Scotiabank says he doesn’t see much room for dollar to rally from current level.
PM Narendra Modi will review highway projects worth Rs 6000 crore, Chetan Bhutani joined us with the details.
The Municipal Corporation of Greater Mumbai has set a June target to break ground on the proposed Rs 10,000 crore coastal road project, connecting Princess Street to Versova. Karishma Asoodani reports.
Axis Bank has classified Shilpi Cable Technologies as a fraud account. Shantanu Guha Ray joined us with more details.
In talks to sell MF and broking units for Rs 600 Cr
Bain Capital , Warburg, Yes Bank and IndusInd said to have expressed interest
The AMC business had an AUM of Rs 66392 cr and PAT of Rs 58 cr in FY17
The Securities business had a PAT of Rs 29 cr in FY17
Economic Times Reports
Taj Mansingh auction to begin on 19th June18 as per NDMC notice
NDMC - New Delhi Municipality Council
Potential bidders can submit bids starting from 18th May
The hotel is a 292 room five star hotel currently operated by IHCL
Zydus Gets final approval from USFDA for Methylprednisolone
Will be manufactured at formulations manufacturing facility at Moraiya, Ahmedabad
Also received final approval to market Cinacalcet Hydrochloride Tablets
Will be manufactured at facility at SEZ, Ahmedabad